In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

US guidelines recommend the PRECISE-DAPT score to assess bleeding risk. The European approach uses this or the ARC-HBR score, ...

Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top ...

Antiplatelet use can lead to improved cardiovascular ... risks while benefiting from the protective effects of antiplatelet ...

The following is a summary of “Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet ...

Oral anticoagulant or antiplatelet medication use had no substantial effect on the accuracy of multitarget stool DNA testing for colorectal cancer, according to a study published in Gastro Hep ...

In addition, maximal medical therapy was loosely defined in CAVATAS and could consist of antiplatelet agents or anticoagulation with warfarin. Inconsistencies in medical treatment have also ...

The findings showed that P2Y12 inhibitors were more effective than aspirin in reducing the risk of heart attacks and strokes.